Brussels, 12/01/2001 (Agence Europe) - The European Commission has cleared the acquisition, for the sum of $1.24 billion, of the company Block Drug by the British company SmithKline Beecham. Block Drug operates under the name of Stafford-Miller in several countries outside the United States. SmithKline Beecham (turnover $12.55 billion in 1999) is a multinational operating in the research, development and marketing of pharmaceutical products, vaccines, over-the-counter medicines and oral care...